• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在实验性感染溃疡分枝杆菌期间,IFN-γ 依赖性的巨噬细胞激活被毒素(mycolactone)所损害。

IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone.

机构信息

Life and Health Sciences Research Institute, School of Health Sciences, University of Minho, Braga, Portugal.

出版信息

J Immunol. 2010 Jan 15;184(2):947-55. doi: 10.4049/jimmunol.0902717. Epub 2009 Dec 11.

DOI:10.4049/jimmunol.0902717
PMID:20008288
Abstract

Buruli ulcer, caused by Mycobacterium ulcerans infections, is a necrotizing skin disease whose pathogenesis is associated with the exotoxin mycolactone. Despite the relevance of this emergent disease, little is known on the immune response against the pathogen. Following the recent demonstration of an intramacrophage growth phase for M. ulcerans, we investigated the biological relevance of IFN-gamma and the antimycobacterial mechanisms activated by this cytokine in M. ulcerans-infected macrophages. Three M. ulcerans strains were tested: 5114 (mutant mycolactone-negative, avirulent strain); 94-1327 (intermediate virulence); and 98-912 (high virulence). We show in this study that IFN-gamma is expressed in mouse-infected tissues and that IFN-gamma-deficient mice display increased susceptibility to infection with strains 5114 and, to a lesser extent, 94-1327, but not with the highly virulent strain. Accordingly, IFN-gamma-activated cultured macrophages controlled the proliferation of the avirulent and the intermediate virulent strains. Addition of mycolactone purified from strain 98-912 to cultures of IFN-gamma-activated macrophages infected with the mycolactone-negative strain led to a dose-dependent inhibition of the IFN-gamma-induced protective mechanisms, involving phagosome maturation/acidification and increased NO production, therefore resulting in increased bacterial burdens. Our findings suggest that the protection mediated by IFN-gamma in M. ulcerans-infected macrophages is impaired by the local buildup of mycolactone.

摘要

布鲁里溃疡是由溃疡分枝杆菌感染引起的一种坏死性皮肤疾病,其发病机制与外毒素(mycolactone)有关。尽管这种新兴疾病具有重要意义,但人们对其病原体的免疫反应知之甚少。最近有研究表明溃疡分枝杆菌在巨噬细胞内存在一个生长阶段,因此我们研究了 IFN-γ在其中的作用及其激活的抗分枝杆菌机制。我们检测了三种溃疡分枝杆菌菌株:5114(突变型无(mycolactone)阴性、弱毒菌株);94-1327(中等毒力);98-912(高毒力)。研究表明,IFN-γ在感染组织中表达,IFN-γ 缺陷型小鼠对 5114 株和 94-1327 株的感染易感性增加,但对高毒力菌株 98-912 株的易感性没有增加。因此,IFN-γ 激活的培养巨噬细胞控制了弱毒和中等毒力菌株的增殖。将从 98-912 株中提取的 mycolactone 添加到感染无(mycolactone)阴性菌株的 IFN-γ 激活的巨噬细胞培养物中,导致 IFN-γ 诱导的保护性机制被剂量依赖性抑制,涉及吞噬体成熟/酸化和增加的 NO 产生,从而导致细菌载量增加。我们的研究结果表明,在感染溃疡分枝杆菌的巨噬细胞中,IFN-γ 介导的保护作用受到局部积聚的 mycolactone 的损害。

相似文献

1
IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone.在实验性感染溃疡分枝杆菌期间,IFN-γ 依赖性的巨噬细胞激活被毒素(mycolactone)所损害。
J Immunol. 2010 Jan 15;184(2):947-55. doi: 10.4049/jimmunol.0902717. Epub 2009 Dec 11.
2
Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.溃疡分枝杆菌毒性大环内酯类物质麦角硫因内酯在体外和体内均可调节宿主免疫反应及溃疡分枝杆菌的细胞定位。
Cell Microbiol. 2005 Sep;7(9):1295-304. doi: 10.1111/j.1462-5822.2005.00557.x.
3
Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection.分枝杆菌内酯介导的对溃疡分枝杆菌感染的巨噬细胞肿瘤坏死因子产生的抑制作用对感染控制具有重要意义。
Infect Immun. 2007 Aug;75(8):3979-88. doi: 10.1128/IAI.00290-07. Epub 2007 May 21.
4
Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin.溃疡分枝杆菌短暂胞内阶段对宿主免疫反应的调节:内源性分枝杆菌内酯毒素的作用
Cell Microbiol. 2005 Aug;7(8):1187-96. doi: 10.1111/j.1462-5822.2005.00546.x.
5
Immune response to infection with Mycobacterium ulcerans.对溃疡分枝杆菌感染的免疫反应。
Infect Immun. 2001 Mar;69(3):1704-7. doi: 10.1128/IAI.69.3.1704-1707.2001.
6
Systemic suppression of interferon-gamma responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans.在布氏杆菌溃疡患者中,由细胞外病原体溃疡分枝杆菌引起的病变经手术切除后,全身性干扰素-γ反应的抑制得以缓解。
J Leukoc Biol. 2006 Jun;79(6):1150-6. doi: 10.1189/jlb.1005581. Epub 2006 Mar 10.
7
Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.细胞免疫在卡介苗或缺乏 mycolactone 的溃疡分枝杆菌接种后对实验性布鲁里溃疡提供短暂保护。
PLoS One. 2012;7(3):e33406. doi: 10.1371/journal.pone.0033406. Epub 2012 Mar 8.
8
Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma.小鼠细胞内分枝杆菌引起的慢性感染:与巨噬细胞释放前列腺素E2的关联以及吲哚美辛、胞壁酰二肽或γ干扰素注射的逆转作用
J Immunol. 1986 Mar 1;136(5):1820-7.
9
Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.溃疡分枝杆菌巨噬细胞内生长阶段的证据。
Infect Immun. 2007 Feb;75(2):977-87. doi: 10.1128/IAI.00889-06. Epub 2006 Dec 4.
10
A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin.从患有致命感染的非洲爪蟾属物种的实验室菌落中分离出的一种新发现的分枝杆菌病原体产生了一种新型的分枝杆菌内酯,即溃疡分枝杆菌大环内酯毒素。
Infect Immun. 2005 Jun;73(6):3307-12. doi: 10.1128/IAI.73.6.3307-3312.2005.

引用本文的文献

1
A refined low-dose murine model of infection to assess integrated immune networks in Buruli ulcer pathogenesis.一种用于评估布鲁里溃疡发病机制中综合免疫网络的改良低剂量小鼠感染模型。
mBio. 2025 Sep 10;16(9):e0193125. doi: 10.1128/mbio.01931-25. Epub 2025 Aug 18.
2
Exploring Mycolactone-The Unique Causative Toxin of Buruli Ulcer: Biosynthetic, Synthetic Pathways, Biomarker for Diagnosis, and Therapeutic Potential.探索分枝杆菌内酯——布鲁里溃疡的独特致病毒素:生物合成、合成途径、诊断生物标志物及治疗潜力
Toxins (Basel). 2024 Dec 6;16(12):528. doi: 10.3390/toxins16120528.
3
A human model of Buruli ulcer: The case for controlled human infection and considerations for selecting a Mycobacterium ulcerans challenge strain.
人体布鲁里溃疡模型:人为感染控制的案例和选择溃疡分枝杆菌挑战株的考虑因素。
PLoS Negl Trop Dis. 2023 Jun 29;17(6):e0011394. doi: 10.1371/journal.pntd.0011394. eCollection 2023 Jun.
4
Inhibition of the SEC61 translocon by mycolactone induces a protective autophagic response controlled by EIF2S1-dependent translation that does not require ULK1 activity.美拉诺菌素通过抑制 SEC61 易位酶诱导依赖于 EIF2S1 翻译的保护性自噬反应,该反应不依赖于 ULK1 活性。
Autophagy. 2022 Apr;18(4):841-859. doi: 10.1080/15548627.2021.1961067. Epub 2021 Aug 23.
5
Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana.加纳中部地区患有伯里溃疡病的患者中 HIV 合并感染。
BMC Infect Dis. 2021 Apr 8;21(1):331. doi: 10.1186/s12879-021-06009-7.
6
Individual and clinical variables associated with the risk of Buruli ulcer acquisition: A systematic review and meta-analysis.与获得布鲁里溃疡风险相关的个体和临床变量:系统评价和荟萃分析。
PLoS Negl Trop Dis. 2020 Apr 8;14(4):e0008161. doi: 10.1371/journal.pntd.0008161. eCollection 2020 Apr.
7
Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model.在低剂量小鼠挑战模型中针对溃疡分枝杆菌感染的疫苗特异性免疫反应。
Infect Immun. 2020 Feb 20;88(3). doi: 10.1128/IAI.00753-19.
8
Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review.噬菌体疗法作为一种针对分枝杆菌感染的新型治疗方法:全面综述
Infect Drug Resist. 2019 Sep 17;12:2943-2959. doi: 10.2147/IDR.S218638. eCollection 2019.
9
Antimicrobial activity of Mycobacteriophage D29 Lysin B during Mycobacterium ulcerans infection.分枝杆菌噬菌体 D29 溶菌酶 B 对溃疡分枝杆菌感染的抗菌活性。
PLoS Negl Trop Dis. 2019 Aug 19;13(8):e0007113. doi: 10.1371/journal.pntd.0007113. eCollection 2019 Aug.
10
Spontaneous healing of Mycobacterium ulcerans disease in Australian patients.澳大利亚患者中溃疡分枝杆菌病的自发愈合。
PLoS Negl Trop Dis. 2019 Feb 19;13(2):e0007178. doi: 10.1371/journal.pntd.0007178. eCollection 2019 Feb.